Different potencies of angiotensin receptor blockers at suppressing adrenal β-arrestin1-dependent post-myocardial infarction hyperaldosteronism

  • Anastasios Lymperopoulos
  • , Emmanuel Sturchler
  • , Ashley Bathgate-Siryk
  • , Samalia Dabul
  • , Dilayda Garcia
  • , Karlee Walklett
  • , Giuseppe Rengo
  • , Patricia McDonald
  • , Walter J. Koch

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)2805-2806
Number of pages2
JournalJournal of the American College of Cardiology
Volume64
Issue number25
DOIs
StatePublished - Dec 30 2014

ASJC Scopus Subject Areas

  • Cardiology and Cardiovascular Medicine

Keywords

  • Aldosterone/blood
  • Angiotensin II Type 1 Receptor Blockers/therapeutic use
  • Animals
  • Benzimidazoles/therapeutic use
  • Biphenyl Compounds
  • Hyperaldosteronism/prevention & control
  • Myocardial Infarction/complications
  • Rats
  • Tetrazoles/therapeutic use
  • Valine/analogs & derivatives
  • Valsartan

Disciplines

  • Cardiology

Cite this